TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/31/23 16:46 | 3/30/23 | VTYX | Ventyx Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gujrathi Sheila | CA | D | M.d | 603 | 6.03 | 0 | 100 | 0 | D | ||||||||||||||||
3/31/23 16:46 | 3/30/23 | VTYX | Ventyx Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gujrathi Sheila | CA | D | S.d | -3,373 | 33.73 | 0 | -100 | -100 | 0 | D | |||||||||||||||
9/27/19 10:39 | 9/27/19 | GOSS | Gossamer Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gujrathi Sheila | CA | DO | P,CEO | P | 168 | 16.80 | 0 | 10 | 0 | 4,048 | I | ||||||||||||||
11/12/14 20:35 | 11/11/14 | RCPT | Receptos, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gujrathi Sheila | CA | O | Chief Me | S | -3,270 | 108.99 | 0 | -30 | -20 | 121 | D | ||||||||||||||
9/24/14 21:00 | 9/22/14 | RCPT | Receptos, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gujrathi Sheila | CA | O | Chief Me | S | -1,844 | 61.45 | 0 | -30 | -17 | 151 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |